Luis A Nevarez

Statistics

Publications

Citations

694

H-Index

Active since

2018

Affiliations

Rocky Mountain Diabetes and Osteoporosis Center(Current)

Luis A Nevarez is an author at Rocky Mountain Diabetes and Osteoporosis Center specializing in pharmacotherapy, diabetes pharmacotherapy, and glycemic control.

Publications per year

2018–2021

Publications

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 642 citations

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and safety of once‐weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52‐week open‐label, randomized phase III trial

Weiqing Wang, Luis A Nevarez, Ki Ho Song et al. · Diabetes Obesity and Metabolism · 2018 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

1–2 of 2